Daniel Persky
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 06, 2023
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma.Paul A Hamlin, Vasile Musteata, Steven I Park
|Jun 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.Max J Gordon, Andy Kaempf, Andrea Sitlinger
|Nov 20, 2020
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies.Alexey V Danilov, Daniel O Persky
|May 21, 2020
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.Nicole A Carreau, Philippe Armand, Reid W Merryman
|Dec 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.Daniel O Persky, Hongli Li, Lisa M Rimsza
Pageof 1
Frequent Collaborators
1 joint publications
Leslie L Popplewell
1 joint publications
Alexey V Danilov
1 joint publications
Paul A Hamlin
1 joint publications
Vasile Musteata
1 joint publications
Thomas Strack
1 joint publications
Eric T Williams
1 joint publications
Philippe Armand
1 joint publications
Reid W Merryman
1 joint publications
Michael A Spinner
1 joint publications
Alex F Herrera
